- A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA)Masashi Saito
Seta Clinic Group, Chiyoda ku, Tokyo, Japan
Anticancer Res 33:2957-63. 2013..Combination of ALA/DCA, hyperthermotherapy, and cellular immunotherapy may be a low-invasive palliative therapy superior in maintaining quality of life of tumor-bearing terminally ill individuals...
- Zoledronate-activated Vγ9γδ T cell-based immunotherapy is feasible and restores the impairment of γδ T cells in patients with solid tumorsAtsutaka Noguchi
Seta Clinic Group, Seta Clinic Tokyo, 3 6 5 Iidabashi, Chiyoda ku, Tokyo, Japan
Cytotherapy 13:92-7. 2011..Zoledronate-activated Vγ9γδ T cell-based immunotherapy that restores the number of Vγ9γδ T cells in cancer patients may provide another mode of adoptive immunotherapy...